Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L de Haan

Showing results (141-150 of 148) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 148 results.
Schizophrenia Research|April 20, 2020
Do schizotypal or borderline personality disorders predict onset of psychotic disorder or persistent attenuated psychotic symptoms in patients at high clinical risk?H Hadar, H Zhang, L J Phillips, et al.
Psychological Medicine|May 9, 2024
The contribution of cannabis use to the increased psychosis risk among minority ethnic groups in EuropeJ P Selten, M Di Forti, D Quattrone, et al.
Psychological Medicine|May 15, 2023
Tobacco use in first-episode psychosis, a multinational EU-GEI studyT Sánchez-Gutiérrez, E Rodríguez-Toscano, L Roldán, et al.
Schizophrenia Research|July 5, 2024
Self-reported suicidal ideation among individuals with first episode psychosis and healthy controls: Findings from the international multicentre EU-GEI studyC B B C M Heuschen, K Bolhuis, J B Zantvoord, et al.
Epidemiology and Psychiatric Sciences|September 27, 2022
Genetic and psychosocial stressors have independent effects on the level of subclinical psychosis: findings from the multinational EU-GEI studyB Pignon, H Peyre, A Ayrolles, et al.
Psychological Medicine|November 22, 2024
Cannabis use and cognitive biases in people with first-episode psychosis and their siblingsL Roldan, T Sánchez-Gutiérrez, I Fernández-Arias, et al.
Molecular Psychiatry|June 3, 2015
Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortiumT G M van Erp, D P Hibar, J M Rasmussen, et al.
Molecular Psychiatry|August 19, 2015
Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortiumT G M van Erp, D P Hibar, J M Rasmussen, et al.
Pageof 15

Showing results (141-150 of 148) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 148 results.
Schizophrenia Research|April 20, 2020
Do schizotypal or borderline personality disorders predict onset of psychotic disorder or persistent attenuated psychotic symptoms in patients at high clinical risk?H Hadar, H Zhang, L J Phillips, et al.
Psychological Medicine|May 9, 2024
The contribution of cannabis use to the increased psychosis risk among minority ethnic groups in EuropeJ P Selten, M Di Forti, D Quattrone, et al.
Psychological Medicine|May 15, 2023
Tobacco use in first-episode psychosis, a multinational EU-GEI studyT Sánchez-Gutiérrez, E Rodríguez-Toscano, L Roldán, et al.
Schizophrenia Research|July 5, 2024
Self-reported suicidal ideation among individuals with first episode psychosis and healthy controls: Findings from the international multicentre EU-GEI studyC B B C M Heuschen, K Bolhuis, J B Zantvoord, et al.
Epidemiology and Psychiatric Sciences|September 27, 2022
Genetic and psychosocial stressors have independent effects on the level of subclinical psychosis: findings from the multinational EU-GEI studyB Pignon, H Peyre, A Ayrolles, et al.
Psychological Medicine|November 22, 2024
Cannabis use and cognitive biases in people with first-episode psychosis and their siblingsL Roldan, T Sánchez-Gutiérrez, I Fernández-Arias, et al.
Molecular Psychiatry|June 3, 2015
Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortiumT G M van Erp, D P Hibar, J M Rasmussen, et al.
Molecular Psychiatry|August 19, 2015
Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortiumT G M van Erp, D P Hibar, J M Rasmussen, et al.
Pageof 15